VOSORITIDE
vosoritide 400 microgram injection [10 vials] (&) inert substance diluent [10 x 0.5
mL syringes], 1 pack
VOSORITIDE (13275Q)
13275Q
Manner of administration:Injection
Restriction
Indication: Achondroplasia
Treatment phase: Initial treatment
Restriction
Indication: Achondroplasia
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 3 | Max qty units: 30 | # of repeats: 5 | DPMQ: $27,840.93 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Voxzogo | |||||
